Tower View Wealth Management LLC Has $5.01 Million Stake in Marsh & McLennan Companies, Inc. $MRSH

Tower View Wealth Management LLC reduced its stake in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH) by 13.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 26,989 shares of the financial services provider’s stock after selling 4,064 shares during the quarter. Marsh & McLennan Companies comprises about 2.5% of Tower View Wealth Management LLC’s portfolio, making the stock its 16th biggest position. Tower View Wealth Management LLC’s holdings in Marsh & McLennan Companies were worth $5,007,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently bought and sold shares of the stock. Third View Private Wealth LLC acquired a new position in Marsh & McLennan Companies during the 4th quarter worth $2,555,000. Baillie Gifford & Co. lifted its holdings in Marsh & McLennan Companies by 5.8% during the 4th quarter. Baillie Gifford & Co. now owns 87,167 shares of the financial services provider’s stock worth $16,171,000 after buying an additional 4,806 shares in the last quarter. Deprince Race & Zollo Inc. lifted its holdings in Marsh & McLennan Companies by 19.7% during the 4th quarter. Deprince Race & Zollo Inc. now owns 114,498 shares of the financial services provider’s stock worth $21,242,000 after buying an additional 18,845 shares in the last quarter. Palouse Capital Management Inc. lifted its holdings in Marsh & McLennan Companies by 35.0% during the 4th quarter. Palouse Capital Management Inc. now owns 12,857 shares of the financial services provider’s stock worth $2,385,000 after buying an additional 3,332 shares in the last quarter. Finally, Clear Creek Financial Management LLC lifted its holdings in Marsh & McLennan Companies by 5.2% during the 4th quarter. Clear Creek Financial Management LLC now owns 1,449 shares of the financial services provider’s stock worth $269,000 after buying an additional 72 shares in the last quarter. Institutional investors own 87.99% of the company’s stock.

Marsh & McLennan Companies Stock Performance

Shares of MRSH stock opened at $173.47 on Tuesday. Marsh & McLennan Companies, Inc. has a 52-week low of $164.89 and a 52-week high of $239.34. The company has a market capitalization of $83.98 billion, a PE ratio of 20.58, a PEG ratio of 2.29 and a beta of 0.75. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 1.20. The firm has a 50 day simple moving average of $173.02.

Marsh & McLennan Companies (NYSE:MRSH) last posted its earnings results on Thursday, January 29th. The financial services provider reported $2.12 earnings per share for the quarter, topping the consensus estimate of $1.97 by $0.15. The company had revenue of $6.60 billion for the quarter, compared to analyst estimates of $6.52 billion. Marsh & McLennan Companies had a net margin of 15.42% and a return on equity of 31.60%. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period last year, the business posted $1.87 earnings per share. As a group, sell-side analysts predict that Marsh & McLennan Companies, Inc. will post 9.61 earnings per share for the current fiscal year.

Marsh & McLennan Companies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Thursday, April 9th will be issued a $0.90 dividend. The ex-dividend date is Thursday, April 9th. This represents a $3.60 annualized dividend and a yield of 2.1%. Marsh & McLennan Companies’s dividend payout ratio (DPR) is 42.70%.

Wall Street Analyst Weigh In

Several research analysts have issued reports on MRSH shares. JPMorgan Chase & Co. reduced their price objective on Marsh & McLennan Companies from $226.00 to $206.00 and set an “overweight” rating on the stock in a report on Thursday, April 9th. Wells Fargo & Company reduced their price objective on shares of Marsh & McLennan Companies from $203.00 to $178.00 and set an “equal weight” rating on the stock in a research note on Thursday, April 9th. Mizuho reduced their price objective on shares of Marsh & McLennan Companies from $199.00 to $193.00 and set a “neutral” rating on the stock in a research note on Monday. Barclays reduced their price objective on shares of Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 8th. Finally, Citigroup raised their price objective on shares of Marsh & McLennan Companies from $201.00 to $205.00 and gave the company a “neutral” rating in a research note on Tuesday, February 3rd. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, ten have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Marsh & McLennan Companies currently has an average rating of “Hold” and a consensus target price of $205.60.

Insiders Place Their Bets

In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,655 shares of the stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $183.30, for a total value of $3,052,861.50. Following the sale, the chief executive officer directly owned 116,811 shares in the company, valued at approximately $21,411,456.30. This trade represents a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 0.38% of the company’s stock.

Marsh & McLennan Companies Profile

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.